{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-032969","form_type":"8-K","ticker":"MBRX","cik":"0001659617","company_name":"Moleculin Biotech, Inc.","filed_at":"2026-10-20T11:00:28+00:00","discovered_at":"2026-10-20T11:05:01.360961+00:00","generated_at":"2026-10-20T11:05:17.464368+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Moleculin Biotech sets 1-for-20 reverse split effective Oct 20, 2026; shares outstanding fall to ~1.05M","bullets":["Board approved 1-for-20 reverse split after stockholders authorized a ratio of 1-for-2 to 1-for-20 at the Oct 9, 2026 annual meeting.","Split effective 12:01 a.m. ET Oct 20, 2026; MBRX trades post-split on Nasdaq Capital Market with new CUSIP 60855D507.","Outstanding shares drop from ~20.91 million to ~1.05 million; authorized shares stay at 500 million; par value unchanged at $0.001.","No fractional shares issued — holders receive cash equal to the fraction times the 5-day average closing price before the split.","Restated post-split FY2025 net loss per share $(568.38) vs pre-split $(28.42); net loss $33.56M in FY2025 vs $26.05M in FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-032969","json":"https://secwatch.observer/filing/0001437749-26-032969.json","markdown":"https://secwatch.observer/filing/0001437749-26-032969.md","text":"https://secwatch.observer/filing/0001437749-26-032969.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926032969/0001437749-26-032969-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926032969/mbrx20261015d_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-20T11:05:17.464368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}